aap

Q2/2015 sales above guidance at EUR 6.5 million; 27% LOQTEQ® growth in H1/2015

aap Implantate AG / aap: Q2/2015 sales above guidance at EUR 6.5 million; 27% LOQTEQ® growth in H1/2015 . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.

aap Implantate AG (XETRA: AAQ.DE) generated sales totalling EUR 6.5 million in the second quarter of 2015 (Q2/2014: EUR 8.1 million) according to preliminary figures, thereby exceeding the guidance provided in May of EUR 5.0 million to EUR 6.1 million. Total sales in the first half of the current financial year thus amounted to EUR 13.6 million (H1/2014: EUR 14.2 million).  

Sales in EUR million	Q2/2015	Q2/2014	Change
Trauma	3.2	2.9	8%
thereof LOQTEQ®	2.0	1.8	15%
Biomaterials	3.2	4.9	-34%
Projects	0.0	0.1	-82%
Other	0.1	0.2	-50%
Total sales	6.5	8.1	-20%